RE
Replimune Group, Inc.
REPL · NASDAQ
$13.24 -8.50% (-$1.23)
1M +5.86%
Market Cap $1.21B
P/E Ratio -
Div. Yield -
ROE 159.33%
Bulios Fair Price
$12.11
8.5% downside
Trenutna cena
$13.24
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica REPL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 11.49x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 33.11%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 136.14%
ROE 159.33%
ROA 117.65%
Debt
69 /100
Low Debt/Equity 0.26x
Current ratio 5.23x
Int. coverage -30.82x
Stability
78 /100
Stable Beta 0.94x
EPS volatility 8.40%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o REPL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sushil Patel
Employees
465
Headquarters
Woburn
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report